FTM/NB Hairloss from HRT, treatment started and feeling hopeless.
    Transgender 4/18/2025

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    ๐Ÿ’Š Dutasteride (oral) 0.5mg daily
    ๐Ÿ’Š Minoxidil (oral) 0.25mg daily
    ๐Ÿ’ง Ketoconazole (topical) 2% 2x weekly
    ๐Ÿ’ง Dr. Dercos shampoo and conditioner (topical) alternating every second day
    the tone is ๐Ÿ˜ž negative.

    Other terms

    A non-binary individual experienced hair loss after stopping hormone replacement therapy and is using oral Dutasteride, oral Minoxidil, and ketoconazole shampoo. They are hopeful for regrowth but may use wigs due to the high cost and uncertain effectiveness of additional treatments like mesotherapy and PRP.
    View this post in the Community โ†’

    Similar Community Posts Join

    5 / 1000+ results

    Related Research

    6 / 1000+ results
      Female Pattern Alopecia: Current Perspectives

      research Female Pattern Alopecia: Current Perspectives

      42 citations, August 2013 in “International Journal of Women's Health”
      Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.
      Androgenetic Alopecia: An Evidence-Based Treatment Update

      research Androgenetic Alopecia: An Evidence-Based Treatment Update

      151 citations, May 2014 in “American Journal of Clinical Dermatology”
      Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.
      Androgenetic Alopecia: An Update

      research Androgenetic Alopecia: An Update

      88 citations, January 2013 in “Indian Journal of Dermatology, Venereology and Leprology”
      Minoxidil and finasteride effectively treat hair loss.
      Common Dermatologic Conditions

      research Common Dermatologic Conditions

      14 citations, April 2014 in “Medical Clinics of North America”
      The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.